Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

1,137

currently held

Exits tracked

410

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-26

HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days ago

HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin

Treble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days ago

Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Compagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks ago

Compagnie Financière et de Participations Roullier2 weeks ago

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Convergent Novo Holdings Growth Investments	Biotech	United States	Novo Holdings	2024	2yr	Active	–	–
Corryn Biotechnologies Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2026	0yr	Active	–	–
Coultreon Biopharma Novo Holdings Seed Investments	Biotech	United States	Novo Holdings	2026	0yr	Active	–	–
Countagen Almi Invest (Regional funds)	Biotech	Sweden	Almi Invest	2022	4yr	Active	–	–
Cour Pharmaceuticals Angelini Ventures	Biotech	United States	Angelini Ventures	2023	3yr	Active	–	–
CRANE BIOSCIENCES Norrsken Accelerator	Biotech	United Kingdom	Norrsken Accelerator	2024	2yr	Active	–	–
CraneBio Vento Fund I	Biotech	United Kingdom	Vento	2023	3yr	Active	–	–
Crystalys Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2024	2yr	Active	–	–
CubaseBio Almi Invest (Regional funds)	Biotech	Sweden	Almi Invest	2026	0yr	Active	–	–
Curadis S-Refit AG	Biotech	Germany	Sobera Capital	2016	10yr	Active	–	–
Cyclana Bio Eka Ventures Fund II	Biotech	UK	EKA Ventures	2025	1yr	Active	–	–
Cytely Fund II	Biotech	Sweden	Ugly Duckling Ventures	2025	1yr	Active	–	–
CytoSeek UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2019	7yr	Active	–	–
Cytospire Criteria Bio Ventures	Biotech	United Kingdom	Caixa Capital Risc	2026	0yr	Active	–	–
DaltonTx IQ Capital Fund IV	Biotech	UK	IQ Capital Partners	2025	1yr	Active	–	–
Dania Tx Eir Ventures I	Biotech	Denmark	Eir Ventures	2023	3yr	Active	–	–
Deka Biosciences Leaps by Bayer	Biotech	United States	Leaps by Bayer	2021	5yr	Active	–	–
Depth Charge Therapeutics AFB Fund II	Biotech	Ireland	AdBio Partners	2021	5yr	Active	–	–
Digna Biotech Sodena Direct	Biotech	Spain	Sodena	2003	23yr	Active	–	–
Dimericon HTGF IV	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2023	3yr	Active	–	–
DreamFold IQ Capital Fund IV	Biotech	Canada	IQ Capital Partners	2025	1yr	Active	–	–
Drug Discovery and Clinic Utopia SIS	Biotech	Italy	Utopia SIS	2022	4yr	Active	–	–
Dualyx BioDiscovery 6	Biotech	France	Andera Partners	2023	3yr	Active	–	–
Edgewise Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2019	7yr	Active	–	–
Edvince Almi Invest (Regional funds)	Biotech	Sweden	Almi Invest	2016	10yr	Active	–	–
EG 427 BioDiscovery 7	Biotech	France	Andera Partners	2025	1yr	Active	–	–
Egetis Therapeutics Flerie Invest	Biotech	Sweden	Flerie	2017	9yr	Active	–	–
Empros Pharma Flerie Invest	Biotech	Sweden	Flerie	2013	13yr	Active	–	–
Enduro Genetics Supernova Innovation 3	Biotech	Denmark	Supernova Invest	2025	1yr	Active	–	–
Engimmune Therapeutics Novo Holdings Seed Investments	Biotech	Switzerland	Novo Holdings	2022	4yr	Active	–	–
Enveda Biosciences Kinnevik	Biotech	United States	Kinnevik	2023	3yr	Active	–	–
EpiEndo Pharmaceuticals Flerie Invest	Biotech	Iceland	Flerie	2021	5yr	Active	–	–
Epigenica Navigare Ventures	Biotech	Sweden	Navigare Ventures	2025	1yr	Active	–	–
EpilepsyGTx XGEN Venture Life Sciences Fund	Biotech	United Kingdom	XGen Venture SGR	2025	1yr	Active	–	–
Epoqe Pharma Lundbeckfonden BioCapital	Biotech	Denmark	Lundbeckfonden BioCapital	2021	5yr	Active	–	–
Ermium Therapeutics Erganeo	Biotech	France	Erganeo	2019	7yr	Active	–	–
Erytech BioDiscovery 5	Biotech	France	Andera Partners	2017	9yr	Active	–	–
Esperas TVM Life Science Ventures	Biotech	Canada	TVM Capital Life Science	2015	11yr	Active	–	–
Euroespes Moira Capital Desarrollo	Biotech	Spain	Moira Capital Partners	2018	8yr	Active	–	–
eversyn IBG Risikokapitalfonds IV	Biotech	Germany	bmp Ventures AG	2025	1yr	Active	–	–
Evolving Therapeutics Angels Capital	Biotech	Spain	Angels Capital	2025	1yr	Active	–	–
Evonetix Molten Ventures Balance Sheet	Biotech	UK	Molten Ventures	2018	8yr	Active	–	–
Exapto Generations powered by EDHEC	Biotech	France	Ring Capital	2024	2yr	Active	–	–
Exicure Abingworth Bioventures VI	Biotech	US	Abingworth	2019	7yr	Active	–	–
Expedition Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2025	1yr	Active	–	–
ExpressionEdits BlueYard Capital Fund III	Biotech	UK	BlueYard Capital	2024	2yr	Active	–	–
F2G Limited Novo Holdings Growth Investments	Biotech	United Kingdom	Novo Holdings	2016	10yr	Active	–	–
Fermentas International Summit Partners Growth Equity Fund VII	Biotech	USA	Summit Partners	–	–	Active	–	–
Fermify Simon Capital Evergreen	Biotech	Austria	Simon Capital	2023	3yr	Active	–	–
Flamingo Therapeutics BioDiscovery 5	Biotech	France	Andera Partners	2018	8yr	Active	–	–

Portfolio companies.21,000+ PE-backed.

Portfolio companies.
21,000+ PE-backed.